Results 41 to 50 of about 152 (81)

Itraconazole-Associated Fixed Drug Eruption in a Patient With Allergic Bronchopulmonary Aspergillosis: A Case Report and Review of the Literature. [PDF]

Cureus
Thomas RS, Joseph G, Bhatti N, Badyal DK.   +3 more
europepmc   +1 more source

Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination. [PDF]

Clin Exp Dermatol, 2022
Wantavornprasert K, Noppakun N, Klaewsongkram J, Rerknimitr P.   +3 more
europepmc   +1 more source

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions. [PDF]

Front Med (Lausanne), 2022
Copaescu AM, Ben-Shoshan M, Trubiano JA.
europepmc   +1 more source

Dietary Collagen Supplements Might Not Be Completely Innocent: A Case of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by a Collagen Supplement. [PDF]

Indian J Dermatol, 2022
Al Bahri ZA, Al Ali AA, Al-Azri ARS, Al Balushi AA, Al Hinai MH, Al Busaidi KN.   +5 more
europepmc   +1 more source

Delayed-Onset Localized Bullous Pemphigoid on an Umbilical Hernia Repair Scar: An Example of Ruocco's Immunocompromised Cutaneous District. [PDF]

Cureus
Tercan E, Cetinarslan T, Temiz P, Sagcan Tercan SY, Ermertcan AT.   +4 more
europepmc   +1 more source

Guidelines for the management of adult penicillin allergy in community and specialist settings in Australia and New Zealand: An AGREE II and Delphi-based approach. [PDF]

J Allergy Clin Immunol Glob
Lucas M, Kehoe J, Stiles S, Salter SM, Loprete J, Hornung CJ, Martin L, Ali SB, Farmer RS, DeLuca J, Fernando S, Katelaris C, Kolawole H, Trubiano J, Perrett KP, Smith W, Thien F, Koplin JJ, Vale S, Yun J, National Allergy Council Drug Allergy consortium∗.   +20 more
europepmc   +1 more source

Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis Settings. [PDF]

J Allergy Clin Immunol Pract
Selim R, Thwala B, Porter M, Chimbetete T, Sethosa P, Malope T, Choshi P, Pedretti S, Dlamini S, Phillips EJ, Lehloenya R, Peter J.   +11 more
europepmc   +1 more source

Accurately describing drug allergies and adverse drug reactions: The Australian Delphi Consensus on Drug Allergy Terminology. [PDF]

J Allergy Clin Immunol Glob
Kehoe J, Stiles S, Stiles S, Vale S, Yun J, Thien F, Trubiano J, Kim K, Smith W, Lucas M, National Allergy Council Drug Allergy Consortium.   +10 more
europepmc   +1 more source

Real-World Data on Severe Cutaneous Adverse Reactions to Drugs. [PDF]

Pharmaceuticals (Basel)
Zyryanov S, Terehina E, Butranova O, Asetskaya I, Polivanov V, Yudin A.   +5 more
europepmc   +1 more source

Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system. [PDF]

Saudi Pharm J
Alshammari TM.
europepmc   +1 more source